Concise answers when you need the essentials, with deeper clinical context and transparent source links when the decision needs more scrutiny.
Search by active ingredient or familiar medicine name.
Dabigatran etexilate is a direct oral anticoagulant converted in the body to dabigatran. It reduces blood-clot formation and is used for selected people with atrial fibrillation, venous thromboembolism or recent elective hip or knee replacement surgery.
An oral anticoagulant converted in the body to dabigatran. It helps prevent or treat harmful blood clots in selected adults and children.
Dabrafenib mesilate is a targeted anti-cancer treatment that blocks abnormal BRAF signalling in tumours with a suitable BRAF V600 mutation. It is licensed for selected melanomas and non-small cell lung cancer in adults, and with trametinib for certain childhood gliomas.
Dacarbazine citrate is intravenous cytotoxic chemotherapy. The selected UK product is licensed for metastatic malignant melanoma and, in combination chemotherapy, advanced Hodgkin lymphoma and certain advanced adult soft-tissue sarcomas.
Dacomitinib monohydrate is an oral targeted anticancer treatment called a protein tyrosine kinase inhibitor. It is licensed as first treatment for adults with locally advanced or metastatic non-small-cell lung cancer that has an activating EGFR mutation.
Dactinomycin is cytotoxic chemotherapy that blocks cancer-cell growth by binding to DNA. In the UK, it is used for selected solid tumours and gestational trophoblastic neoplasia, usually within specialist combination or multimodal treatment.
Dalbavancin hydrochloride is a long-acting antibiotic that kills susceptible Gram-positive bacteria. In the UK, it is licensed for acute bacterial infections of the skin and tissues beneath the skin in adults and children from birth. A healthcare professional administers it into a vein.
Dalteparin sodium is a low molecular weight heparin anticoagulant injected under the skin. It reduces blood clotting and is used in selected patients to treat or prevent clots and manage clot-related complications in unstable coronary disease.
Danaparoid sodium is an injectable anticoagulant that mainly reduces factor Xa activity and limits clot formation. In the UK, it is licensed to prevent deep-vein thrombosis around general or orthopaedic surgery and to treat thromboembolism when urgent injectable anticoagulation is needed because of current or previous heparin-induced thrombocytopenia.
Danicopan is an oral complement factor D inhibitor licensed as an add-on to ravulizumab or eculizumab for adults with paroxysmal nocturnal haemoglobinuria (PNH) who still have haemolytic anaemia.
Dantrolene sodium is a direct-acting skeletal muscle relaxant. Oral capsules treat chronic severe spasticity, while the intravenous formulation is used with supportive measures during malignant hyperthermia emergencies.
Dantrolene sodium hemiheptahydrate is a direct-acting skeletal muscle relaxant. This intravenous product treats malignant hyperthermia, a life-threatening reaction involving uncontrolled muscle activity and heat production.
Dapagliflozin is a prescription SGLT2 inhibitor that acts mainly in the kidneys. Selected UK products are licensed for type 2 diabetes, symptomatic chronic heart failure and chronic kidney disease; heart and kidney use does not require diabetes.
Combines an SGLT2 inhibitor with a biguanide in one tablet for adults with type 2 diabetes when metformin-based treatment is insufficient or both ingredients are already taken separately.
A fixed-dose oral combination of the SGLT2 inhibitor dapagliflozin and DPP-4 inhibitor saxagliptin for specified circumstances in adults with type 2 diabetes.
Dapsone is a sulfone with antibacterial and anti-inflammatory effects. Oral dapsone is used for leprosy, certain inflammatory skin disorders and prevention of specified infections in people with weakened immunity.
Daptomycin is a cyclic lipopeptide antibiotic given into a vein for certain serious Gram-positive infections of the skin and soft tissue, bloodstream or right side of the heart.
Daratumumab targets CD38 on abnormal plasma cells. It is mainly used alone or with other treatments for multiple myeloma. The subcutaneous formulation is also licensed for high-risk smouldering multiple myeloma and newly diagnosed systemic AL amyloidosis.
Darbepoetin alfa is an erythropoiesis-stimulating agent that acts like the natural kidney hormone erythropoietin. It is used for symptomatic anaemia in chronic kidney failure and in certain adults receiving chemotherapy.
Daridorexant hydrochloride is a dual orexin receptor antagonist that reduces the brain’s drive to stay awake. It is licensed for adults whose insomnia has lasted at least 3 months and considerably affects daytime functioning.
Darifenacin is an antimuscarinic treatment for adults with overactive bladder syndrome. It reduces urinary urgency, frequency and leakage caused by urgency by relaxing bladder activity.
Darifenacin hydrobromide is an antimuscarinic that reduces involuntary bladder-muscle activity. It is licensed for adults with urinary urgency, increased frequency or urge incontinence caused by overactive bladder syndrome.
Darolutamide is an androgen receptor inhibitor used to slow the growth of certain prostate cancers. In the UK, it is used for high-risk non-metastatic castration-resistant disease and metastatic hormone-sensitive disease alongside androgen deprivation therapy, sometimes with docetaxel.
Darunavir is an antiretroviral protease inhibitor used to treat HIV-1. It is taken with ritonavir or cobicistat to increase its level, alongside other antiretroviral medicines.
Darunavir ethanolate is an HIV protease inhibitor used with other antiretroviral treatments for HIV-1. Ritonavir or cobicistat slows its breakdown to maintain effective exposure.
Darunavir propylene glycolate is an antiretroviral protease inhibitor used with ritonavir and other antiretrovirals to treat HIV-1 infection. It lowers viral replication but does not cure HIV.
Dasatinib is a targeted anticancer treatment called a tyrosine kinase inhibitor. It is used for certain Philadelphia chromosome-positive leukaemias, including chronic myeloid leukaemia and acute lymphoblastic leukaemia.
Dasatinib anhydrous is a targeted protein kinase inhibitor used for Philadelphia chromosome-positive blood cancers, mainly chronic myeloid leukaemia and selected forms of acute lymphoblastic leukaemia under specialist haematology care.
Dasatinib monohydrate is a targeted anticancer treatment called a tyrosine kinase inhibitor. It is used for Philadelphia chromosome-positive chronic myeloid leukaemia and certain cases of Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Daunorubicin hydrochloride is an anthracycline chemotherapy treatment for acute leukaemia. It is usually given with other anticancer treatments to destroy abnormal blood-forming cells and help induce remission.
Decitabine is an anticancer antimetabolite that changes DNA methylation and can suppress leukaemia cells. The selected Great Britain product is licensed for adults with newly diagnosed acute myeloid leukaemia who are unsuitable for standard induction chemotherapy.
Deferasirox is an oral iron chelator that binds excess iron so it can leave the body, mainly in faeces. Specialist teams prescribe it for iron overload caused by repeated blood transfusions or certain thalassaemia syndromes.
Deferiprone is an oral iron chelator that binds excess iron so it can be removed from the body. It is used for iron overload in thalassaemia major when other chelation is unsuitable or inadequate, sometimes alongside another chelator in specialist care.
Defibrotide is a hospital-administered antithrombotic treatment for severe hepatic veno-occlusive disease, also called sinusoidal obstruction syndrome, following haematopoietic stem-cell transplantation. It helps protect blood-vessel linings and balance clot formation and breakdown.
Deflazacort is an oral corticosteroid that reduces inflammation and immune activity. It is prescribed for severe allergic, inflammatory, autoimmune and blood disorders, and for immunosuppression after transplantation.
Degarelix acetate is a gonadotrophin-releasing hormone (GnRH) antagonist that lowers testosterone. It is used for hormone-dependent prostate cancer, including certain high-risk cancers treated before or alongside radiotherapy.
Delafloxacin meglumine is a fluoroquinolone antibiotic for certain serious bacterial skin infections and community-acquired pneumonia in adults. It is reserved for situations where commonly recommended antibiotics are inappropriate because fluoroquinolones can rarely cause disabling or potentially irreversible reactions.
Delgocitinib is a prescription skin cream and pan-Janus kinase inhibitor. It is licensed for moderate to severe chronic hand eczema in adults when topical corticosteroids are inadequate or inappropriate.
Demeclocycline hydrochloride is a tetracycline antibiotic used for susceptible bacterial infections, including severe acne. It is also licensed for chronic hyponatraemia caused by SIADH associated with malignant disease when water restriction has failed and cirrhosis is absent.
This live attenuated vaccine generates immune responses against all four dengue virus serotypes. It is licensed to prevent dengue disease from age 4, subject to official recommendations. UK recommendations mainly focus on people with likely previous dengue infection who face travel-related or occupational exposure.
Denosumab is a biological antiresorptive treatment that reduces bone breakdown. It is used for osteoporosis and treatment-related bone loss, and in different formulations for bone complications of advanced cancer and selected giant cell tumours of bone.
Depemokimab is a humanised monoclonal antibody that blocks interleukin-5 and reduces eosinophilic inflammation. In the UK, it is an add-on treatment for eligible people with inadequately controlled eosinophilic asthma or severe chronic rhinosinusitis with nasal polyps.
Dequalinium chloride is a locally acting anti-infective antiseptic. The selected UK product is a vaginal tablet licensed to treat bacterial vaginosis, an imbalance of vaginal bacteria.
Desferrioxamine mesilate binds excess iron and aluminium so they can leave the body. It is mainly used for iron overload, acute iron poisoning and selected dialysis-related aluminium overload.
Desflurane is an inhaled general anaesthetic that causes reversible unconsciousness and reduced pain sensation during surgery. In adults it may start or maintain anaesthesia; in children it is licensed only for maintenance.
Desloratadine is a less-sedating antihistamine used to relieve allergic rhinitis and urticaria symptoms, including sneezing, an itchy or runny nose, itchy or watery eyes, itching and hives.
Desmopressin acetate is a synthetic form of arginine vasopressin. It reduces urine production and, when injected for selected bleeding disorders, can temporarily increase certain clotting factors.
Desmopressin acetate trihydrate is a synthetic form of arginine vasopressin, which helps the kidneys conserve water. The selected nasal spray is mainly used for vasopressin-sensitive central diabetes insipidus and specialist testing of kidney concentrating ability.
Desogestrel is an oestrogen-free, progestogen-only contraceptive. It prevents pregnancy mainly by suppressing ovulation.
Desogestrel + ethinylestradiol is a combined oral contraceptive containing a progestogen and an oestrogen. It is licensed to prevent pregnancy.
Deucravacitinib is an oral, selective tyrosine kinase 2 (TYK2) inhibitor licensed for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy.
Deuruxolitinib phosphate is a prescription-only oral JAK inhibitor licensed for adults with severe alopecia areata. It reduces immune signalling involved in inflammation around hair follicles, which can permit hair regrowth.
A fixed combination of three CFTR modulators for cystic fibrosis in people aged 6 years and over who have at least one F508del mutation or another responsive CFTR mutation.
Dexamethasone is a long-acting corticosteroid that reduces inflammation and suppresses immune activity. Oral products treat many steroid-responsive disorders and cerebral swelling; eye drops treat selected inflammation at the front of the eye.
This prescription eye treatment combines dexamethasone, a corticosteroid that reduces inflammation, with the antibiotics neomycin and polymyxin B. It is licensed for steroid-responsive eye conditions requiring preventive antibacterial cover, after viral and fungal disease have been excluded.
Docusate sodium is a laxative that helps water and fats enter stools, making them softer. It is available as oral capsules, oral liquids and a rectal micro-enema; licensed uses differ by product.
Donidalorsen sodium is an antisense oligonucleotide used to prevent recurrent hereditary angioedema (HAE) attacks in adults and adolescents aged 12 years and older. It does not treat an attack that is already happening.
Doxazosin mesilate is an alpha-1 blocker used in selected UK products for high blood pressure and urinary symptoms caused by benign prostate enlargement. It relaxes blood vessels and muscle around the prostate and bladder outlet.
Doxycycline hyclate is a prescription-only tetracycline antibiotic used to treat susceptible infections and prevent malaria in appropriate travellers.
Duloxetine hydrochloride is a prescription serotonin and noradrenaline reuptake inhibitor (SNRI). Depending on the product licence, it is used for depression, generalised anxiety disorder, diabetic peripheral neuropathic pain or stress urinary incontinence in women.